Medicinal use of cannabis: RPS seeks pharmacists’ views

high quality cannabis plant

A new survey into pharmacists’ views on the medicinal use of cannabis has been launched by the Royal Pharmaceutical Society (RPS). The results of the survey will be used to inform draft RPS policy on the matter, which will then be presented to the national pharmacy boards for discussion.

“The RPS Pharmaceutical Science Expert Advisory Panel and others have proposed that the Home Office should move cannabis out of Schedule 1 of the Misuse of Drugs Regulations 2001,” said Maurice Hickey, policy project pharmacist at RPS Scotland.

“A motion was passed in support of the schedule change at the RPS Conference on 14 September 2015.”

A listing in Schedule 1 indicates that a drug has absolutely no therapeutic value, and re-scheduling the drug would enable scientists to more easily undertake research on the short and long-term effects of cannabis use and allow pharmacists and doctors to possess and supply the drug to their patients.

The RPS is interested to hear the views of its members on this subject and welcomes your replies and comments.

The survey remains open until 12pm on 31 July 2017. Members can access the link to the survey on the RPS website.

Last updated
Citation
The Pharmaceutical Journal, July 2017;Online:DOI:10.1211/PJ.2017.20203220